Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
NOCIL Limited (NOCIL.NS)
INR166.67
-1.72 (-1.02%)
IN NSE Basic Materials Chemicals - Specialty
Address
Mafatlal House 400020
Mumbai, IN
Mumbai, IN
CEO
Hrishikesh Arvind Mafatlal
Website
nocil.com
IPO
2002-07-01
ISIN INE163A01018
Also trades on
Bombay Stock Exchange · NOCIL.BO (INR)
National Stock Exchange of India · NOCIL.NS (INR)
Description
NOCIL Limited is a prominent manufacturer and supplier of specialized chemicals catering to India's tire and broader rubber processing sectors. The company's extensive product range includes various additives like vulcanization accelerators, anti-degradants, antioxidants, inhibitors for premature vulcanization, and stabilizers for post-vulcanization. Additionally, NOCIL offers solutions formulated to enhance the thermal stability of rubber compounds' cross-links. While primarily serving the domestic market, the company also exports its goods internationally. Established in 1961, NOCIL Limited is headquartered in Mumbai, India.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
INR166.67
-1.72 (-1.02%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
0.01
Float Shares
90.99M
Free Float %
54.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.06% | -10.44% | +0.15% | +9.20% | -4.10% | +9.01% | -10.53% | -26.70% | -16.38% | +204.44% | +599.58% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
166.67
DCF (Unlevered)
433.34
+160.0%
DCF (Levered)
445.92
+167.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
43% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | +1 |
Quality scores
Altman Z-Score
6.16
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals - Specialty: +4.7%-6.4% Q1'26: -2.7% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-46.0% Q1'26: -19.2% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+15.9% Q1'26: +9.8% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+3.5% Q1'26: +2.2% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+2.3% Q1'26: +1.7% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.2% Q1'26: +1.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.08× ★ Q1'26: 0.10× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 1996 actual |
Mar 1997 actual |
Mar 1998 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 5 Rev. Ana. 5 EPS Ana. |
Mar 2027 4 Rev. Ana. 4 EPS Ana. |
Mar 2028 4 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
13.19B
est.
|
11.51B
est.
|
11.17B
est.
|
7.19B
est: 7.20B (-0.2%)
|
7.15B
est: 778.30M (+818.9%)
|
7.42B
est: 7.45B (-0.4%)
|
9.55B
est: 9.79B (-2.4%)
|
10.30B
est: 10.84B (-5.0%)
|
8.38B
est: 8.52B (-1.6%)
|
9.13B
est: 9.00B (+1.4%)
|
15.61B
est: 14.90B (+4.8%)
|
16.17B
est: 15.94B (+1.4%)
|
14.37B
est: 14.20B (+1.2%)
|
13.93B
est: 14.02B (-0.7%)
|
13.17B
12.09B – 13.36B
-6.1% YoY
|
15.04B
14.16B – 16.30B
+14.2% YoY
|
17.15B
15.39B – 19.98B
+14.0% YoY
|
| EBITDA |
2.02B
est.
|
1.73B
est.
|
1.67B
est.
|
1.17B
est: 1.10B (+6.4%)
|
1.43B
est: 119.05M (+1,100.4%)
|
1.68B
est: 1.14B (+47.8%)
|
2.80B
est: 1.50B (+86.3%)
|
3.02B
est: 3.26B (-7.2%)
|
1.86B
est: 2.35B (-20.9%)
|
1.45B
est: 1.87B (-22.6%)
|
2.89B
est: 2.54B (+13.9%)
|
2.59B
est: 2.86B (-9.6%)
|
2.34B
est: 1.94B (+20.4%)
|
1.37B
est: 1.92B (-28.3%)
|
1.80B
1.65B – 1.83B
-6.1% YoY
|
2.06B
1.94B – 2.23B
+14.2% YoY
|
2.34B
2.11B – 2.73B
+14.0% YoY
|
| EBIT |
1.54B
est.
|
1.32B
est.
|
1.28B
est.
|
1.02B
est: 840.10M (+22.0%)
|
1.28B
est: 90.78M (+1,313.0%)
|
1.49B
est: 869.37M (+71.1%)
|
2.56B
est: 1.15B (+123.3%)
|
2.78B
est: 2.73B (+1.7%)
|
1.52B
est: 2.09B (-27.2%)
|
1.07B
est: 1.39B (-22.9%)
|
2.41B
est: 1.89B (+27.4%)
|
2.03B
est: 2.13B (-4.6%)
|
1.82B
est: 1.42B (+27.6%)
|
838.30M
est: 1.41B (-40.3%)
|
1.32B
1.21B – 1.34B
-6.1% YoY
|
1.51B
1.42B – 1.63B
+14.2% YoY
|
1.72B
1.54B – 2.00B
+14.0% YoY
|
| Net Income |
1.27B
est.
|
914.95M
est.
|
646.73M
est.
|
570.99M
est: 587.05M (-2.7%)
|
782.62M
est: 735.91M (+6.3%)
|
1.20B
est: 1.08B (+11.9%)
|
1.70B
est: 1.69B (+0.8%)
|
1.85B
est: 1.89B (-2.5%)
|
1.31B
est: 1.42B (-7.7%)
|
884.10M
est: 1.25B (-29.4%)
|
1.76B
est: 1.70B (+3.4%)
|
1.49B
est: 1.17B (+27.5%)
|
1.33B
est: 1.26B (+5.8%)
|
1.03B
est: 1.20B (-14.0%)
|
675.16M
616.81M – 733.50M
-43.6% YoY
|
1.03B
809.84M – 1.19B
+53.2% YoY
|
1.50B
920.41M – 1.93B
+45.1% YoY
|
| SGA |
890.10M
est.
|
776.58M
est.
|
753.30M
est.
|
534.28M
est: 485.84M (+10.0%)
|
245.38M
est: 52.50M (+367.4%)
|
260.91M
est: 502.77M (-48.1%)
|
595.20M
est: 660.26M (-9.9%)
|
659.60M
est: 1.78B (-62.9%)
|
660.40M
est: 1.36B (-51.6%)
|
701.70M
est: 1.78B (-60.5%)
|
808.70M
est: 2.41B (-66.5%)
|
875.50M
est: 2.72B (-67.8%)
|
1.02B
est: 1.49B (-31.5%)
|
1.17B
est: 1.47B (-20.6%)
|
1.38B
1.27B – 1.40B
-6.1% YoY
|
1.57B
1.48B – 1.71B
+14.2% YoY
|
1.79B
1.61B – 2.09B
+14.0% YoY
|
| EPS |
7.59
est.
|
5.51
est.
|
3.90
est.
|
3.55
est: 3.51 (+1.1%)
|
4.87
est: 4.40 (+10.7%)
|
6.00
est: 6.44 (-6.8%)
|
10.35
est: 10.04 (+3.1%)
|
11.19
est: 12.08 (-7.3%)
|
7.89
est: 8.41 (-6.1%)
|
5.33
est: 4.78 (+11.6%)
|
10.58
est: 9.13 (+15.8%)
|
8.95
est: 8.80 (+1.7%)
|
7.98
est: 7.54 (+5.8%)
|
6.17
est: 6.93 (-11.0%)
|
3.90
3.68 – 4.38
-43.7% YoY
|
5.78
4.83 – 7.10
+48.2% YoY
|
7.24
5.49 – 11.53
+25.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-799.46M
OE per share TTM
-4.76
Owner's Yield
-2.60%
Maintenance CapEx ratio
150.19%
Maint CapEx / Avg PPE
72.1%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 7 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Asia Pacific ETF GMF | 0.02% | 89.9K | 0.49% |
| 2 | WisdomTree India Earnings Fund EPI | 0.02% | 430.2K | 0.84% |
| 3 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.02% | 145.1K | 0.65% |
| 4 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 43.6K | 0.46% |
| 5 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 101.2K | 0.29% |
| 6 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.00% | 679.58 | 0.56% |
| 7 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 12.3K | 0.39% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
641.3K
Shares Outstanding
167.02M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hrishikesh Arvind Mafatlal | Executive Chairman | 38M | male |
| V. S. Anand | MD & Executive Director | 24M | male |
| Kashmeera Prabhu | Head of HR | — | female |
| Milind Shevte | Vice President of Marketing | — | male |
| Prasanna Pandit | President of Operations & Technical | — | male |
| R. Desai | Vice President of Production, Operations & Personnel | — | male |
| Srinivasan | President of Finance & Chief Financial Officer | — | male |
| Amit K. Vyas | Head of Legal, Assistant Vice President of Legal, Compliance Officer & Company Secretary | — | male |
| Vikas Padalkar | AVP & Head of Research and Development | — | — |
| Brijesh Parikh | Site Head - Dahej | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NOCIL.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
